Insider Stock Trading History of Novak Rodger


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Novak Rodger since year 2005. The trader's CIK number is 1682017. At the time of this reporting, Novak Rodger is the Chief Executive Officer of Crispr Therapeutics Ag . (stock ticker symbol CRSP). See this page for all insider trading activities at Crispr Therapeutics Ag .


Stock purchases, sales, and option exercises reported by insider Novak Rodger since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-31 CRSP Crispr Therapeutics Ag Sale 14,617 20.87 305,071
2017-09-05 CRSP Crispr Therapeutics Ag Option Ex 3,853 1.81 6,973
2017-09-05 CRSP Crispr Therapeutics Ag Sale 3,853 20.33 78,319
2017-08-30 CRSP Crispr Therapeutics Ag Sale 58,103 20.31 1,179,955
2017-08-28 CRSP Crispr Therapeutics Ag Sale 17,692 20.06 354,919
2017-08-30 CRSP Crispr Therapeutics Ag Option Ex 5,722 1.81 10,356
2017-08-28 CRSP Crispr Therapeutics Ag Option Ex 17,692 1.81 32,022
2017-06-22 CRSP Crispr Therapeutics Ag Option Ex 10,825 1.81 19,593
2017-06-22 CRSP Crispr Therapeutics Ag Sale 10,825 15.37 166,391
2017-06-21 CRSP Crispr Therapeutics Ag Option Ex 11,578 1.81 20,956
2017-06-20 CRSP Crispr Therapeutics Ag Option Ex 3,252 1.81 5,886
2017-06-19 CRSP Crispr Therapeutics Ag Option Ex 15,392 1.81 27,859
2017-06-21 CRSP Crispr Therapeutics Ag Sale 11,578 15.02 173,843
2017-06-20 CRSP Crispr Therapeutics Ag Sale 3,252 15.00 48,786
2017-06-19 CRSP Crispr Therapeutics Ag Sale 15,392 15.00 230,880
2017-06-09 CRSP Crispr Therapeutics Ag Option Ex 1,100 1.81 1,991
2017-06-08 CRSP Crispr Therapeutics Ag Sale 4,203 15.00 63,045
2017-06-09 CRSP Crispr Therapeutics Ag Sale 1,100 15.08 16,583
2017-06-08 CRSP Crispr Therapeutics Ag Option Ex 4,203 1.81 7,607
2017-05-30 CRSP Crispr Therapeutics Ag Option Ex 3,650 1.81 6,606
2017-05-30 CRSP Crispr Therapeutics Ag Sale 3,650 15.02 54,830
2017-05-17 CRSP Crispr Therapeutics Ag Sale 25,923 16.03 415,571
2017-05-16 CRSP Crispr Therapeutics Ag Sale 24,077 16.50 397,294
2017-05-17 CRSP Crispr Therapeutics Ag Option Ex 25,923 1.81 46,920
2017-05-16 CRSP Crispr Therapeutics Ag Option Ex 24,077 1.81 43,579
2017-05-05 CRSP Crispr Therapeutics Ag Option Ex 616 1.81 1,114
2017-05-05 CRSP Crispr Therapeutics Ag Sale 616 16.93 10,425
2017-05-04 CRSP Crispr Therapeutics Ag Sale 13,191 16.37 215,963
2017-05-03 CRSP Crispr Therapeutics Ag Sale 20,269 16.34 331,296
2017-05-04 CRSP Crispr Therapeutics Ag Option Ex 13,191 1.81 23,875
2017-05-02 CRSP Crispr Therapeutics Ag Sale 15,924 16.53 263,239
2017-05-03 CRSP Crispr Therapeutics Ag Option Ex 20,269 1.81 36,686
2017-05-02 CRSP Crispr Therapeutics Ag Option Ex 15,924 1.81 28,822
2017-04-19 CRSP Crispr Therapeutics Ag Option Ex 47,706 1.81 86,347
2017-04-20 CRSP Crispr Therapeutics Ag Option Ex 2,294 1.81 4,152
2017-04-19 CRSP Crispr Therapeutics Ag Sale 47,706 18.09 862,906
2017-04-20 CRSP Crispr Therapeutics Ag Sale 2,294 17.37 39,851

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Novak Rodger (Chief Executive Officer of Crispr Therapeutics Ag at the time of this reporting) see the Securities and Exchange Commission (SEC) website.